Your browser doesn't support javascript.
loading
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
Parakh, Sagun; Park, John J; Mendis, Shehara; Rai, Rajat; Xu, Wen; Lo, Serigne; Drummond, Martin; Rowe, Catherine; Wong, Annie; McArthur, Grant; Haydon, Andrew; Andrews, Miles C; Cebon, Jonathan; Guminski, Alex; Kefford, Richard F; Long, Georgina V; Menzies, Alexander M; Klein, Oliver; Carlino, Matteo S.
Afiliação
  • Parakh S; Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia.
  • Park JJ; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia.
  • Mendis S; La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia.
  • Rai R; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia.
  • Xu W; The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Lo S; Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia.
  • Drummond M; The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Rowe C; Melanoma Institute Australia, Sydney, New South Wales 2060, Australia.
  • Wong A; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
  • McArthur G; The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Haydon A; Melanoma Institute Australia, Sydney, New South Wales 2060, Australia.
  • Andrews MC; The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Cebon J; Melanoma Institute Australia, Sydney, New South Wales 2060, Australia.
  • Guminski A; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
  • Kefford RF; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
  • Long GV; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
  • Menzies AM; Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia.
  • Klein O; Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia.
  • Carlino MS; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia.
Br J Cancer ; 116(12): 1558-1563, 2017 Jun 06.
Article em En | MEDLINE | ID: mdl-28524161
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Anticorpos Monoclonais Humanizados / Melanoma / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Anticorpos Monoclonais Humanizados / Melanoma / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido